National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Published in Level 2 journals, first or last author from Oslo University Hospital.
Bruun LD, Andersen GØ, Kringen MK, Myhre PL, Halvorsen S, Hansen CH, Molden E, Øie E(2025) Effect of metoprolol exposure following myocardial infarction on future cardiovascular events: a Mendelian randomization study Eur J Clin Pharmacol(in press) DOI 10.1007/s00228-025-03806-w, PubMed 39900827
Alver TN, Bergholtz H, Holm MB, Dorg LT, Skrede ML, Kure EH, Verbeke CS(2025) Spatial transcriptomics reveals cancer and stromal cell heterogeneity between center and invasive front of pancreatic cancer Mod Pathol, 100726(in press) DOI 10.1016/j.modpat.2025.100726, PubMed 39889965
Engseth LHW, Øhrn FD, Schulz A, Röhrl SM(2025) CT-based migration analysis of a tibial component compared to radiostereometric analysis : one-year results of a prospective single-group implant safety study Bone Joint J, 107-B(2), 173-180 DOI 10.1302/0301-620X.107B2.BJJ-2024-0356.R2, PubMed 39889761